The risk of suicidality with selective serotonin reuptake inhibitors.
Antidepressants are efficacious in the treatment of depression but they are not without side effects. The recent findings on the risk of suicide with selective serotonin reuptake inhibitor treatment, however, have raised serious concerns about the risk-benefit ratio of their use. The development of the concerns is traced and the risks discussed, particularly in the child and adolescent group. The prescriber needs to be aware of the issues and of the need for close clinical monitoring of patients started on selective serotonin reuptake inhibitor treatment.
Mahendran
Rathi
R
Senior Consultant Psychiatrist, Institute of Mental Health/Woodbridge Hospital, Singapore. rathi_mahendran@imh.com.sg
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D003865:Major Depressive Disorder / Q000175:diagnosis; D006801:Humans; D018570:Risk Assessment; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D013405:Suicide / Q000706:statistics & numerical data
D017367:Selective Serotonin Reuptake Inhibitors